- Report
- September 2019
- 119 Pages
Global
From €4499EUR$4,950USD£3,869GBP
- Report
- March 2025
- 136 Pages
Global
From €4540EUR$4,995USD£3,904GBP
- Report
- January 2025
- 140 Pages
Global
From €3590EUR$3,950USD£3,087GBP
- Report
- December 2024
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- September 2024
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- February 2026
- 150 Pages
Canada
From €4409EUR$4,850USD£3,790GBP
- Report
- February 2026
- 150 Pages
Germany
From €4409EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4409EUR$4,850USD£3,790GBP
- Report
- February 2026
- 80 Pages
United Kingdom
From €2591EUR$2,850USD£2,227GBP
- Report
- February 2026
- 83 Pages
China
From €2591EUR$2,850USD£2,227GBP
- Report
- February 2026
- 87 Pages
South Korea
From €2591EUR$2,850USD£2,227GBP
- Report
- August 2025
- 150 Pages
Global
From €2872EUR$3,160USD£2,470GBP
€3590EUR$3,950USD£3,087GBP
- Report
- December 2024
- 150 Pages
Global
From €2872EUR$3,160USD£2,470GBP
€3590EUR$3,950USD£3,087GBP
- Report
- November 2025
- 150 Pages
China
From €4409EUR$4,850USD£3,790GBP
- Report
- July 2025
- 150 Pages
United Kingdom
From €4409EUR$4,850USD£3,790GBP
- Report
- July 2025
- 150 Pages
Italy
From €4409EUR$4,850USD£3,790GBP
- Report
- April 2025
- 150 Pages
India
From €4409EUR$4,850USD£3,790GBP
- Report
- January 2025
- 48 Pages
Global
From €2272EUR$2,499USD£1,953GBP
- Report
- January 2025
- 38 Pages
Global
From €2272EUR$2,499USD£1,953GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more